Search - tctmd.com

Displaying 581 - 600 of 606

Sort: Relevancy | Date

News Conference News Cell Therapy 2012

Expedited Cell Therapy After STEMI Shows Promise

January 29, 2012

News Daily News

STEMI Patients Not Achieving Recommended Transfer Times for PCI

L.A. McKeown

December 05, 2011

News Daily News

Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level

Yael L. Maxwell

October 13, 2011

News Daily News

Pre-PCI Hydration Feasible, Reduces Kidney Damage in STEMI Patients

Caitlin E. Cox

October 07, 2011

News Daily News

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

Jason Kahn

September 26, 2011

News Daily News

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

L.A. McKeown

September 20, 2011

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Conference News

Halting Clopidogrel in First Year Following Acute MI Hazardous

September 01, 2011

News Daily News

Delayed Primary PCI Generally Superior to Early Fibrinolysis for STEMI

July 25, 2011

News Daily News

Ticagrelor Gains FDA Approval for Use in ACS

Caitlin E. Cox

July 22, 2011

News Daily News

Prasugrel Fails to Tame Platelets in One-Quarter of ACS Patients Undergoing PCI

July 18, 2011

News Daily News

Meta-analysis: Selective Use of Small-Molecule GPIs Best in NSTE ACS Patients

Caitlin E. Cox

July 08, 2011

News Daily News

Bleeding in ACS Patients Takes Center Stage in ESC Position Paper

July 05, 2011

News Daily News

BARC: New Bleeding Definitions Aim to Standardize Trial Endpoints

L.A. McKeown

June 17, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

News Daily News

Syntax Score Predicts 1-Year Risk in ACS Patients

June 06, 2011

News Daily News

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

L.A. McKeown

June 03, 2011

News Conference News

RECLOSE 2-ACS: Poor Responders Show Poor Outcomes Despite Higher Clopidogrel Dose

Caitlin E. Cox

May 18, 2011

News Daily News

Lack of Benefit, Potential Harm REVEALed with EPO in STEMI Patients

Jason Kahn

May 12, 2011

Advertisement

Expedited Cell Therapy After STEMI Shows Promise

STEMI Patients Not Achieving Recommended Transfer Times for PCI

Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level

Pre-PCI Hydration Feasible, Reduces Kidney Damage in STEMI Patients

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

ESC Congress 2011: Drugs, Devices Work Together

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

Halting Clopidogrel in First Year Following Acute MI Hazardous

Delayed Primary PCI Generally Superior to Early Fibrinolysis for STEMI

Ticagrelor Gains FDA Approval for Use in ACS

Prasugrel Fails to Tame Platelets in One-Quarter of ACS Patients Undergoing PCI

Meta-analysis: Selective Use of Small-Molecule GPIs Best in NSTE ACS Patients

Bleeding in ACS Patients Takes Center Stage in ESC Position Paper

BARC: New Bleeding Definitions Aim to Standardize Trial Endpoints

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Syntax Score Predicts 1-Year Risk in ACS Patients

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

RECLOSE 2-ACS: Poor Responders Show Poor Outcomes Despite Higher Clopidogrel Dose

Lack of Benefit, Potential Harm REVEALed with EPO in STEMI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content